Clinical trial
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
NCT06755086 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 6, 2025
- Completion date
- December 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors